Global Neonatal Intensive Care Respiratory Devices Market to Grow at 6% CAGR, Driven by Preterm Births by 2030

The global neonatal intensive care respiratory devices market is expected to grow at a CAGR of ~6% during the forecast period. Rising incidence of preterm births and associated respiratory complications, increasing adoption of non-invasive ventilation techniques, technological advancements in neonatal ventilators and CPAP systems, and growing awareness regarding neonatal care in developing countries are some of the key driving factors supporting market growth. However, the high cost of advanced neonatal respiratory care devices and the associated maintenance expenses remain major restraints impacting the development of the neonatal intensive care respiratory devices market. 

Neonatal intensive care respiratory devices refer to a specialized range of medical equipment designed to support and manage respiratory function in newborns, particularly those born prematurely or with underdeveloped lungs. These devices play a critical role in neonatal intensive care units (NICUs) by ensuring adequate oxygenation and ventilation, thereby reducing the risk or complications associated with respiratory distress syndrome (RDS), bronchopulmonary dysplasia, and other pulmonary conditions.

Some commonly used neonatal respiratory devices include ventilators, continuous positive airway pressure (CPAP) systems, high-flow nasal cannulas (HFNCs), oxygen hoods and incubators, surfactant delivery systems, and apnea monitors. Overall, neonatal intensive care respiratory devices are vital for reducing neonatal morbidity and mortality, especially in preterm and low-birth-weight infants, by offering tailored and life-sustaining respiratory support.

To request a free sample copy of this report, please visit below
https://meditechinsights.com/neonatal-intensive-care-respiratory-devices-market/request-sample/

Rising incidence of preterm births and related respiratory issues is driving demand for neonatal intensive care respiratory devices

One of the primary factors fueling growth in the neonatal intensive care respiratory devices market is the increasing global incidence of preterm births. According to a 2023 study published in The Lancet, preterm birth rates have remained largely unchanged over the past decade, with 13.4 million babies (9.9% of all births) born preterm in 2020 and highlighting that nearly 15% of these occurred before 32 weeks’ gestation, requiring advanced neonatal care. Additionally, it also stated that Southern Asia and sub-Saharan Africa account for the highest burden, highlighting the urgent need for improved care infrastructure and data systems in these regions.

Premature infants pose a high risk of neonatal respiratory distress syndrome (RDS), a surfactant deficiency-related lung condition linked to prematurity. The incidence of RDS increases as gestational age decreases. This rise in preterm births and respiratory complications is significantly increasing the demand for neonatal ventilators, CPAP systems, and monitoring devices. These devices are essential for stabilizing premature infants, improving survival rates, and reducing long-term complications. 

Technological advancements are revolutionizing neonatal respiratory care with enhanced precision and efficiency

New technologies have transformed neonatal respiratory care, thereby enabling safer, smarter, and more efficient respiratory support solutions for improved neonatal care outcomes. Devices such as advanced CPAP (Continuous Positive Airway Pressure) devices, high-frequency ventilators, and automated oxygen delivery systems offer better control of airflow and oxygen levels, tailored to the delicate physiology of neonates, which reduces the risk of lung injury and supports healthy development in premature and critically ill infants.

Moreover, integration of AI-driven monitoring tools, real-time data analytics, and wireless connectivity allows for continuous assessment and timely intervention. These smart systems facilitate continuous tracking of vital signs, early detection of respiratory distress, and prompt clinical interventions, thereby minimizing complications and improving survival rates. For instance, in April 2025, AngelEye Health announced AIVision, which is an AI-powered enhancement to its NICU bedside camera system that uses computer vision to detect early signs of respiratory distress, neuromotor risk, and other critical conditions, thereby providing real-time, data-driven insights to improve neonatal care. Such advancements are not only improving patient outcomes but also easing the workload of healthcare professionals, thereby driving the demand for next-generation respiratory devices in neonatal intensive care units (NICUs).

Recent developments in the neonatal intensive care respiratory devices market

The neonatal intensive care respiratory devices market has seen notable product approvals and regulatory milestones in recent years, reflecting growing innovation and investment in neonatal care aimed at improving respiratory support for newborns and premature infants. For instance-

• In July 2023, Drägerwerk AG & Co. KGaA announced that it has received FDA approval for its latest mechanical ventilators, Evita V600, V800, and Babylog VN800, designed for use in both adults, newborns and premature babies
• In May 2023, Sibel Health announced that it received FDA clearance for the ANNE One platform, an advanced wireless monitoring system designed for premature neonates and infants
• In June 2022, Beyond Air announced that it received approval from the FDA for its LungFit PH, to treat term and near-term neonates with hypoxic respiratory failure

Competitive Landscape Analysis

The global neonatal intensive care respiratory devices market comprises of several well-established and emerging players, including GE HealthCare; Drägerwerk AG & Co. KGaA; Fisher & Paykel Healthcare Limited; Inspiration Healthcare Group plc; Hamilton Medical AG; Koninklijke Philips N.V.; Medtronic plc; ZOLL Medical Corporation (Asahi Kasei Corporation); GaleMed Corporation; and ICU Medical, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

 🔗 Want deeper insights? Download the sample report here:
https://meditechinsights.com/neonatal-intensive-care-respiratory-devices-market/request-sample/

Global Neonatal Intensive Care Respiratory Devices Market Segmentation

This report by Medi-Tech Insights provides the size of the global neonatal intensive care respiratory devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on device type and end-user.

Market Size & Forecast (2023-2030), By Device Type, USD Million

•  
• Nebulizers
• Inhalers
• Ventilators
• Continuous Positive Airway Pressure (CPAP) Devices
• Apnea Monitors
• Others

Market Size & Forecast (2023-2030), By End-user, USD Million

•  
• Hospitals
• Specialty Clinics
• Nursing Homes
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
• Latin America
• Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com